FDA drops Zika testing for blood donors

July 10, 2018

(HealthDay)—Individual blood donations will no longer need to be tested for the Zika virus, according to the U.S. Food and Drug Administration.

"When Zika virus first emerged, the unknown course of the epidemic and the observed severe effects from the disease indicated that individual donor testing was needed to ensure the continued safety of the blood supply," Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research, explained in an agency press release. "Now, given the significant decrease in cases of Zika virus infection in the United States and its territories, we are moving away from testing each individual donation to testing pooled donations."

Pooled testing of donations is considered less burdensome and more cost-effective for blood establishments. However, the FDA will continue to monitor the situation closely, and if necessary, reconsider what measures are needed to maintain the safety of the .

Explore further: First test to detect Zika in blood donations approved

More information: More Information

Related Stories

First test to detect Zika in blood donations approved

October 9, 2017
(HealthDay)—The cobas Zika test has been approved by the U.S. Food and Drug Administration—the first approved screening test to detect the Zika virus in blood donations.

Screening blood donations for Zika virus is costly, low yield

May 11, 2018
(HealthDay)—Screening blood donations for Zika virus (ZIKV) in the United States is costly with low yield, according to a study published in the May 10 issue of the New England Journal of Medicine.

US urges all donated blood undergo tests for Zika

August 26, 2016
Donated blood should be tested for the Zika virus, which can cause birth defects, US regulators warned Friday amid a mounting outbreak of the mosquito-borne virus in the United States.

Research addresses the threat of Zika virus to the US blood supply

March 27, 2017
Investigators have shown that certain screening methods that detect the genetic material of Zika virus can be used to ensure that donated blood supplies remain free of the virus.

U.S. blood supply safe from Zika virus, officials say

April 7, 2017
(HealthDay)—U.S. blood banks are confident they have the tools to protect America's blood supply from possible new Zika virus outbreaks during the upcoming mosquito season.

FDA grants use of experimental blood test for Zika screening

March 30, 2016
Federal health officials are granting use of an experimental blood test to screen blood for Zika virus, an emergency step designed to protect local blood supplies from the mosquito-borne virus.

Recommended for you

Researchers a step closer to understanding how deadly bird flu virus takes hold in humans

November 19, 2018
New research has taken a step towards understanding how highly pathogenic influenza viruses such as deadly bird flu infect humans.

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.